Aytu BioPharma Inc (AYTU)
2.94
-0.02
(-0.68%)
USD |
NASDAQ |
May 17, 16:00
2.95
+0.01
(+0.34%)
After-Hours: 20:00
Aytu BioPharma Enterprise Value: 12.88M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 12.88M |
| May 16, 2024 | 12.99M |
| May 15, 2024 | 13.55M |
| May 14, 2024 | 15.00M |
| May 13, 2024 | 15.16M |
| May 10, 2024 | 14.72M |
| May 09, 2024 | 14.39M |
| May 08, 2024 | 13.77M |
| May 07, 2024 | 13.55M |
| May 06, 2024 | 13.55M |
| May 03, 2024 | 13.27M |
| May 02, 2024 | 13.27M |
| May 01, 2024 | 12.62M |
| April 30, 2024 | 12.16M |
| April 29, 2024 | 12.16M |
| April 26, 2024 | 12.68M |
| April 25, 2024 | 12.33M |
| April 24, 2024 | 12.10M |
| April 23, 2024 | 11.63M |
| April 22, 2024 | 12.16M |
| April 19, 2024 | 12.05M |
| April 18, 2024 | 12.05M |
| April 17, 2024 | 12.51M |
| April 16, 2024 | 12.44M |
| April 15, 2024 | 11.44M |
| Date | Value |
|---|---|
| April 12, 2024 | 12.60M |
| April 11, 2024 | 13.88M |
| April 10, 2024 | 14.42M |
| April 09, 2024 | 15.22M |
| April 08, 2024 | 14.89M |
| April 05, 2024 | 14.44M |
| April 04, 2024 | 14.33M |
| April 03, 2024 | 13.94M |
| April 02, 2024 | 13.38M |
| April 01, 2024 | 13.16M |
| March 28, 2024 | 13.44M |
| March 27, 2024 | 13.66M |
| March 26, 2024 | 13.66M |
| March 25, 2024 | 13.52M |
| March 22, 2024 | 13.44M |
| March 21, 2024 | 13.11M |
| March 20, 2024 | 12.60M |
| March 19, 2024 | 12.44M |
| March 18, 2024 | 12.60M |
| March 15, 2024 | 12.49M |
| March 14, 2024 | 12.49M |
| March 13, 2024 | 13.50M |
| March 12, 2024 | 14.05M |
| March 11, 2024 | 14.05M |
| March 08, 2024 | 14.00M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.837M
Minimum
Sep 14 2023
176.01M
Maximum
Mar 24 2020
42.22M
Average
15.97M
Median
Jun 16 2023
Enterprise Value Benchmarks
| Regen BioPharma Inc | 3.516M |
| Clearday Inc | 71.79M |
| Bioxytran Inc | 22.19M |
| Shuttle Pharmaceuticals Holdings Inc | 3.480M |
| CEL-SCI Corp | 63.47M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.22M |
| Revenue (Quarterly) | 22.93M |
| Total Expenses (Quarterly) | 20.57M |
| EPS Diluted (Quarterly) | -0.04 |
| Gross Profit Margin (Quarterly) | 70.65% |
| Profit Margin (Quarterly) | -0.96% |
| Earnings Yield | -137.4% |
| Normalized Earnings Yield | -112.97 |